Introduction
The study of signal transduction is currently so broad that the only meaningful approach to describe its details is to focus on a specific example and where possible, note how the specifics can be generalized. The hallmark of an allergic reaction also is the secretion of mediators into the tissue or blood, where they act on a variety of organs to produce the hypersensitivity response. In the context of allergic diseases, T lymphocytes play a role in allergic inflammatory reaction. Signal transduction through T lymphocyte antigen receptor is believed to result in the activation of key signal transducing systems such as the phosphatidylinositol 4,5-bisphosphate (PIP2)-specific phospholipase C-γ (PLC-γ). Phospholipase C (PLC) generates the second messengers inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DG) by metabolizing inositol-containing phospholipids such as phophatidylinositol 4,5-biphosphate. IP3 releases calcium from intracellular storage vesicles, thereby increasing cytosolic-free calcium. DG activates PKC, which in turn induces the activation of various transcription factors. Calcium mobilization may also take place through G protein-dependent activation of PLC. However, T lymphocyte activation via the T cell receptor (TCR) has been shown to occur in the absence of activation of PLC (O'Rourke and Mescher, 1988) and it is demonstrated that PLC-mediated hydrolysis of PIP2 is not sufficient to stimulate T cell proliferation (Exton, 1994) . Therefore, it remains unclear that the mechanism of signal transduction between the ligation of TCR with allergen and secretion of arachidonic acid in allergic inflammatory reaction.
House dust mites (HDMs) are the most important source of indoor aeroallergens (Plattis-Mills TAE and de Weck AL, 1989) . Antigens from two common house dust mite species are Dermatophagoides farinae (Der f) and Dermatophagoides pteronyssinus Der f 2 activates phospholipase D in hum an T lym phocytes from Derm atophagoides farinae specific allergic individuals: Involvem ent of protein kinase C-α (Der p). These antigens are group 2 allergens produced by D. farinae and D. pteronyssinus, respectively, having the amino acid sequence similar to each other (Chua et al., 1990; Yuuki et al., 1991) . Der f and Der p are believed to be the major cause for allergic disease, because group 2 allergen-specific IgE antibodies are found in sera of allergic patients (Holck et al., 1986; Yasueda et al., 1986 Yasueda et al., , 1989 van der Zee et al., 1988; Heymann et al., 1989; Baldo and Donovan, 1990; Smith et al., 2001; Jeong et al., 2002) .
Phospholipase D (PLD) is a widely distributed enzyme that hydrolyzes phosphatidylcholine, a major phospholipids in the cell membrane, to form phosphatidic acid (PA) which acts by itself as a cellular messenger (Exton, 1990 (Exton, , 1999 or can be transformed by PA phosphohydrolase into diacyglycerol (DAG), which is essential for the activation of protein kinase C (PKC) (Nishizuka, 1995) . Recently, PLD has been shown to be coupled to TCR in the leukemic T cell line, Jurkat, resulting in the induction of proliferation of T cells (Reid et al., 1997) and activated by Der p 1 in peripheral blood mononuclear cells from allergic patients (Oh et al., 2000) .
In this study, we evaluated whether Der f 2 induces PLD activation in T cells isolated from allergic individuals. In addition, we have explored an insight of the mechanism of PLD activation by confirming the involvement of PLD activity in the allergic reaction induced by Der f 2 in allergic T-cells.
M aterials and M ethods Subjects
Six patients who referred with symptoms of allergic diseases had positive skin prick tests to house dust mite (Dermatophagoides farinae) extracts and mean of total serum IgE level was 765.3 IU/ml and the mean of Der f specific IgE level was 89.7 IU/ml. Der f specific IgE was measured by using UniCap assay (Upjohn-Pharmacia, Sweden) as shown Table 1 . This study was permitted by Ethical Committee of Hanyang University, Guri Hospital. The mean age of the patients was 20.3 years old. Among the healthy people who do not have any clinical and family history of allergy, three healthy volunteers with serum IgE levels (mean value: 32.8 IU/ml) were included.
Skin prick tests and serum IgE levels
Skin prick tests were performed with allergen extracts of house dust mite (ALK, Copenhagen, Denmark; Greer Lab). Histamine was used as a positive control (10 mg/ml, ALK, Copenhagen, Denmark), and a diluent of an unbuffered saline containing 0.03% human serum albumin (ALK, Copenhagen, Denmark), was used as a negative control. Reactions to each skin test solution were measured 15 min after the pricks. The contours of each wheal reaction were outlined with a fine filter tip pen. The contours were then transferred to the record sheet by means of translucent tapes. The size of each wheal was documented as the mean of the longest diameter (a) and the diameter perpendicular to it at its mid-point (b): (a + b)/2. Wheals with more than half of the histamine reaction after substracting the response to the diluent control were considered as expressions of clear-cut positively. Total serum IgE was measured by the paper radioimmunosorbent test (Kabi-Pharmacia, Uppsala, Sweden). The lower detection limit of IgE was 1.5 IU/ml.
CD4 T lym phocytes purification and culture
Fifty ml of whole blood was collected from each subject at each setting and total 10 times. Fifty µl of Rossette Sep antibody cocktail per ml of blood was mixed well with blood and then incubated for 20 min at room temperature. After incubation, sample was diluted with an equal volume of PBS containing 2% FBS and mixed thoroughly. This diluted sample was carefully layered on the top of 15 ml of Hypaque Ficoll density medium to isolate autologous CD4 + T lymphocytes. The sample was centrifuged for 20 min at 1,200 g at room temperature, with the brake off. The enriched cells were removed from the interface between the density medium and plasma and washed with PBS containing 2% FBS. The isolated cells were washed again with PBS containing 2% FBS. One× 10 6 cells of CD4 T lymphocytes were loaded on each well of 24 well culture plate with 5 mg of Der f 2 recombinant protein and 2×10 6 macrophages as antigen presenting cell (APC) and then incubate for 7 days. After incubating, cultured T lymphocytes were washed with RPMI with 1,000 rpm for 5 min at 25 o C. Phorbol 12-myristate 13-acetate (PMA, 1.0 ng/ml) and 10 µg/ml of PHA-P were added to the each well and recultured for another 3 days. After harvesting the cells, remaining supernatant was kept at -20 o C until use.
G eneration of m onocyte-derived m acrophages as antigen presenting cell
Pheripheral blood mononuclear cells (PBMCs) were isolated from heparinized blood by means of FicollPaque (Biochem, Berlin, Germany) density centrifugation. To enrich CD14 + monocytes, 1×10 6 PBMCs per well were incubated for 45 minutes in a 6-well plate (Costar, Bodenheim, Germany) in modified Dulbecco medium supplemented with 3% autologous plasma at 37 o C. After washing the nonadherent cells with prewarmed PBS, the remaining monocytes (purity 90%) were incubated in 3 ml of modified Dulbecco medium supplemented with 3% autologous plasma for 3 days at 37 o C. After washing the nonadherent cells with pre-warmed PBS, the remaining monocytes (purity 90%) were incubated in 3 ml of Dulbecco medium per well supplemented with 1% heat-inactivated autologous plasma, 1,000 U/ml IL-4, and 800 U/ml GM-CSF. Cells were fed with fresh medium every other day. On day 7, the resulting immature macrophages were pulsed with 10 µg/ml Der f 2 and further stimulated with 1000 U/ml TNF-α, 2000 U/ml IL-1β, and 1 µg/ml prostaglandin E2 to induce their full maturation. Mature macrophages were harvested 48 h after stimulation, washed twice, and used for T lymphocyte culture.
Determ ination of PLD activity PLD activity was determined by the formation of phosphatidylbutanol (PBt) as described elsewhere (Kim et al., 2004 (Bligh and Dyer, 1959) , and PBt was separated by a thin layer chromatography using a solvent system of ethyl acetate/iso-octane/acetic acid/ water (110:50:20:100, v/v) (Park et al., 1999) . The regions corresponding to the authentic PBt bands were identified with 0.002% (w/v) primulin in 80% (v/v) acetone, scraped and counted using a liquid scintillation counter.
Im m unoblot analysis
Serum-starved cells on 60 mm dishes (1×10 8 cells/ dish) were incubated with Der f 2 for each indicated times, scraped in PBS and harvested by microcentrifugation. The cells were then resuspended in 200 µl of lysis buffer (50 mM NaCl, 1 mM MgCl2, 2 mM EDTA, 1mM dithiothreitol, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 50 mM Tris-HCl, pH 7.4) and disrupted by sonication. The cytosolic fraction was separated from particulate fraction by centrifugation at 100,000 g for 1 h using a Beckman TL-100 ultracentrifuge. Proteins from membranes and cytosol were separated by 10% SDS-PAGE (10 mg of protein/lane) as described by Laemmli (Laemmli, 1970) and transferred to nitrocellulose membranes using a Bio-Rad semi-dry transfer system. The membranes were blocked for 1 h with 5% (w/v) non-fat milk in TTBS (tris-buffered saline containing 0.01% Tween-20) and then incubated for another 1 h with diluted specific anti-PKC a or β (1.0 µg/ml). Unbound primary antibodies were removed by three washes (10 min each) with TTBS. Detection was performed with the ECL system (Amersham Corp., Buckinghamshire, UK) according to the manufacturer's protocol.
R esult and D iscussion
Isolated T cells from Dermatophagoides farinae specific allergic patients result in an increase of PLD activity determined by a transphosphatidylation reaction with treatment of Der f 2. The effects of Der f 2 on PLD activity in T lymphocytes from allergic and normal individuals after various doses or times of exposure were shown in Figure 1 . A significant effect on PLD activity was seen in T lymphocytes from allergic patients after treatment with 10 mg/ml of Der f 2 for 30 min (P 0.01). The PLD activity was increased above the normal values after treatment with Der f 2 at each dose point examined, and reached to maximal responses after 10 µg/ml exposure ( Figure 1A) . At 30 min, 10 µg/ml of Der f 2 stimulated PLD activity by 2.0-fold in allergic patients. (Figure 1B) .
To determine whether Der f 2-induced PLD stimulation occurred as a consequence of PKC activation, T lymphocytes were exposed to PMA (200 nM) for 24 h before the treatment for 10 mg/ml of Der f 2 ( Figure 2 ). As shown in this figure, PKC downregulation by the long-term treatment of PMA had no intrinsic effect on basal PLD activity. PLD activation by Der f 2 in the allergic T lymphocytes was significantly decreased after down-regulation of PKC (P 0.05), suggesting that PKC was involved in PLD activation by Der f 2 in the allergic T lymphocytes. To confirm the activation of PKC in Der f 2-treated allergic T lymphocytes, we checked the translocation of PKC from cytosol to membrane. Only translocation of PKC-α to membrane from cytosol was found in 10 mg/ml of Der f 2 treated allergic T lymphocytes. But Measurement of PLD activity after the stimulation of 10 mg/ml Der f 2 in T lymphocytes was performed using the PLD activity assays as mean ± SEM from the experiment performed in triplicate. Statistical analyses were performed using the student's t-test and the asterisk represents significant differences (P 0.05) compared with T lymphocytes which were not preincubated with 200 nM PMA for 24 h before stimulation from controls and patients, respectively, the PKC-α translocation was not found in normal T lymphocytes (Figure 3) . Like PKC-β, other PKC isozymes such as PKC-ε, and -ζ, were not responsive to Der f 2 in the allergic T lymphocytes (data not shown). This result confirmed that Der f 2-induced activation of PLD was mediated by PKC-α translocation in the allergic T lymphocytes. To further confirm the role of PKC in PLD, we tried to inhibit PKC with a specific PKC inhibitor. As shown in Figure 4 , increased PLD activity seen in the T lymphocytes from allergic individuals induced by Der f 2 was not observed in the cells pretreated with the PKC inhibitor, Ro320432 (P 0.05). The observation in cells undergoing inflammation is of particular interest since PLD activity is generally known to be involved in immune responses via production of phosphatidic acid, which lead to generation of DG and elevation of intracellular Ca 2+ level, and consequently sphingosine kinase and protein kinase C activation, degranulation, and arachidonic acid release (Knauss et al., 1990; Gemez-Munoz et al., 1994; Liscovitch and Chalifa, 1994; Alirio JM and Janet MA, 2002) . Berridge and Irvine (1984) reported that phospholipase C (PLC) had an important role in the early events of T cell activation. PLC is one of the phospholipases in cell, which catalyzes the hydrolysis of PIP2 into the second messenger, inositol 1,4,5-triphosphate (IP3) and DAG. Moreover, several studies have emphasized the role of tyrosine phosphorylation in T cell activation. But some reports have cast doubt on the necessity of phosphoinositide hydrolysis in T cell activation (June et al., 1990; Mustelin et al., 1990) . The activation of PLD resulting in PA production can generate the various intracellular signaling pathway.
PA as a product of PLD, has mitogenic properties for various cell types (Exton, 1999) . Recently, it is found that PLD has very important role in immune cells signaling via chemokines and chemotactic peptides (Alirio and Janet, 2002) . The antigen receptors on mature and immature T cells are also coupled to PLD activation and that this activation is dependent upon PKC (Reid et al., 1997) . Previously, we have reported that Der p 1-induced PLD activation was probably involved in T cell activation of PBMC cells and Der p1-induced PLD activation partially occurred as a consequence of PKC activation (Oh et al., 2000) . There are many evidences that PKC is a major mediator to activate PLD in response to various agonists. It has been known that treatment of many cell types, with agonists that induce PIP2 hydrolysis or with phorbol esters, stimulates PLD activity, implying that PLD activity can be regulated by PKC (Kiss, 1996) . The expression of mRNA for PKC-α, -β, -ε, and ζ, but not -γ or -δ isozymes, has been detected in T cells (Freire-Moar et al., 1991; Harris et al., 1995; Wang XD et al., 1995) . In the present experiment, Der f 2-induced PLD activation was significantly abrogated by prior long-term exposure to PMA, which has been demonstrated to lead to PKC down-regulation in various cell types (Kraft et al., 1982) and Der f 2-induced PKC α translocation was found in severe allergic patient T cells, suggesting that PLD was activated by PKC α when stimulated allergic T cell with Der f 2. (Figure 2 and 3) .
In this study, when the PKC was down-regulated, Der f 2-induced PLD activation of control T cells was Figure 3 . Membrane translocation of PKC in Der f 2 treated T lymphocytes. The cells were serum-starved for 24 h in 60 mm culture dishes, and stimulated with 10 µg/ml of Der f 2 for 10 min or 30 min. The cells were homogenized and total lysates obtained. 10 µg of lysates were analyzed by 10% SDS-PAGE, and transferred to nitrocellulose membrane. Western blotting using anti-PKC-α and -β antibodies, as described in Materials and Methods, was used to identify the proteins. Abbreviations: C.P, cytosol protein; M.P, membrane protein. 3 H]palmitate and serum-starved for 18 h. Measurement of PLD activity after stimulation of Der f 2 in T lymphocytes was performed using the PLD activity assays as described in Materials and Methods. Data shown are means ± SEM from three separate experiments, each performed in triplicate. Statistical analyses were performed using the student's t-test and the asterisk represents significant differences (P 0.05) compared with untreated T lymphocytes with PKC inhibitor, Ro 320432.
weaker than that of allergic T cells. Moreover, Der f 2-induced PLD activation of control T cells was not inhibited by long-term treatment of PMA to desensitize PKC (Figure 2 ), indicating that another activator, not PKC, might be needed for Der f 2-induced PLD activation in control T cells. PLD activity can be regulated by multiple types of signals (Liscovitch and Chalifa, 1994) . Both heterotrimeric and low molecular weight G proteins have been implicated in PLD activation. Many investigators suggested that small molecular weight G proteins such as ADP-ribosylation factor (ARF) and RhoA are involved in agonistinduced PLD activation in several cell types (GomezCambronero and Keire, 1998) . In case of T cells, a recent report demonstrated that PLD activation was also activated by small molecular weight G proteins, ARF and RhoA (Bacon et al., 1998) . However, it is not yet clear whether these small molecular weight G proteins may be the regulator for Der f 2-induced PLD activation. In this study, PKC-α translocation in allergic T cells was occurred from cytosol to membrane by treatment of Der f 2. Inhibition of PKC-α with Ro320432 inhibited PLD activation induced by Der f 2 treatment to allergic T cells (Figure 3 and 4) . Taken together, we can suggest that PKC-α play an important role in Der f 2-induced PLD activation.
In conclusion, the present results demonstrated that Der f 2 induced activation of PLD in T cells from Dermatophagoides farinae specific allergic individuals and PKC-α played major role in Der f 2-induced PLD stimulation. In this study, we could not investigate possible involvements of the other PLD activators such as small molecular G proteins and certain tyrosine kinases in Der f 2-induced PLD activation pathways because of difficulty to prepare T cells from allergic patients. Further investigation will be required to fill in the missing links, and to demonstrate the relevance of Der f 2-induced PLD activation pathway in clinical setting.
